OptimizeRx (OPRX) Gains from Investment Securities (2019 - 2020)

OptimizeRx (OPRX) reported Gains from Investment Securities of $110390.0 for Q3 2020, down 60.58% on a YoY basis from $280000.0 in Q4 2019, and up 267.97% sequentially from $30000.0 in Q2 2020.

OptimizeRx (OPRX) Gains from Investment Securities (2019 - 2020) Analysis & Trends

OptimizeRx (OPRX) has 2 years of Gains from Investment Securities data on file, last reported at $110390.0 in Q3 2020.

  • For the quarter ending Q3 2020, Gains from Investment Securities fell 60.58% year-over-year to $110390.0; the trailing twelve-month figure through Dec 2020 stood at -$519610.0 (up 18.17% YoY), and the FY2020 full-year result was $140390.0, up 122.11% from the prior year.
  • Gains from Investment Securities climbed to $110390.0 in Q3 2020, from $30000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $280000.0 in Q3 2019 to a low of -$660000.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn
9 Privia Health 3.10 Bn 2.68 Bn -
10 OptimizeRx 120.26 Mn 100.09 Mn 14.93 Mn

Historic Data

Download Data
DateValue
Sep 30, 2020 110,390.00
Sep 30, 2020 110,390.00
Jun 30, 2020 30,000.00
Jun 30, 2020 30,000.00
Dec 31, 2019 -660,000.00
Dec 31, 2019 -660,000.00
Sep 30, 2019 280,000.00
Sep 30, 2019 280,000.00
Jun 30, 2019 -107,000.00
Jun 30, 2019 -107,000.00
Mar 31, 2019 -148,000.00
Mar 31, 2019 -148,000.00